Reactive oxygen species-responsive RNA interference.

Due to oxidative instability, arylboronic acids are not compatible with the solid-phase synthesis of nucleic acids. We solved this problem and, based on these findings, developed siRNA prodrugs activated in the presence of reactive oxygen species (ROS) in vivo . These prodrugs can be used for specific targeting of ROS-rich cancer cells.